CLSA & NIIMBL: A Partnership to Accelerate Innovation in Biopharmaceutical Manufacturing

CLSA & NIIMBL: A Partnership to Accelerate Innovation in Biopharmaceutical Manufacturing

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), in collaboration with California Life Sciences Association, would like to invite you to a regional information session on how NIIMBL members can access funding for collaborative innovation projects that solve real-world biomanufacturing challenges.

• Since its launch in 2017, NIIMBL has authorized $51M in funding across 45 technology and workforce development projects.

Join a growing community of biomanufacturing companies and academic partners (115 members) for an opportunity to connect in a pre-competitive environment to solve common challenges.

Come learn about the extensive benefits of NIIMBL membership including:

• De-risked technology development through a collaborative environment
• Intellectual property benefits derived through NIIMBL-funded projects
• Networking and partnership opportunities
• Member-exclusive workshops and activities

Agenda

3:00 - 4:00 pm | Presentation

4:00 - 4:30 pm | Q&A

4:30 - 6:00 pm | Reception & Networking

Speakers

What is NIIMBL?

NIIMBL is a public-private partnership dedicated to fundamentally advancing U.S. competitiveness in the biopharmaceutical manufacturing industry. With 114 members across the U.S., NIIMBL is the largest consortium dedicated to biopharmaceutical manufacturing in the world. NIIMBL members collaborate in a precompetitive environment on technologies that will bring safe, efficacious products to market faster and with reduce costs.

Since its launch in 2017, NIIMBL has authorized more $43M in funding across 44 technology and workforce development projects.

Learn more about NIIMBL by visiting our website at http://www.niimbl.org

We look forward to seeing you on April 8. If you have any questions, please contact membership@niimbl.org.